Finland vs Syrian Arab Republic: Previously treated cases tested for RR-/MDR-TB
Finland
33.0%
in 2024
Syrian Arab Republic
32.0%
in 2024
Finland rank
158th
Syrian Arab Republic rank
160th
Previously treated cases tested for RR-/MDR-TB over time
- Finland
- Syrian Arab Republic
How they compare
Finland currently reports 33.0% against 32.0% in Syrian Arab Republic, a difference of 1.0%.
The two have swapped places 4 times across 20 shared years of data; in 2005 it was Finland ahead.
Finland ranks 158th and Syrian Arab Republic ranks 160th of 180 countries.
Across the 3 decades both report, Finland averaged higher in 1 and Syrian Arab Republic in 2.
Head to head by decade
| Decade | Finland | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.8% | 7.0% | 58.8% | Finland |
| 2010s | 48.5% | 50.3% | 1.8% | Syrian Arab Republic |
| 2020s | 42.0% | 86.4% | 44.4% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Finland or Syrian Arab Republic?
- Finland, at 33.0% against 32.0% in Syrian Arab Republic as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Finland and Syrian Arab Republic?
- 1.0%, with Finland ahead.
- How many years of comparable data are there for Finland and Syrian Arab Republic?
- 20 years are reported by both, from 2005 to 2024.
- How do Finland and Syrian Arab Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Finland ranks 158th and Syrian Arab Republic ranks 160th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.